Nonacus is on a mission to create a world where early cancer diagnosis, detection and management is simple and universally available.

Headquartered in Birmingham, UK, Nonacus is a leading provider of advanced genetic testing solutions, collaborating with scientists and clinicians to deliver an end-to-end precision oncology workflow. Our technologies support both primary tumour and liquid biopsy analysis, helping to bring earlier, more accurate cancer insights into routine care.

A standout example of this impact is GALEASTM Bladder, our non-invasive bladder cancer test. By removing the need for unnecessary, invasive, and costly hospital procedures, GALEAS Bladder delivers real benefits across the healthcare system:

• Patients gain earlier diagnosis and faster access to treatment—driving better outcomes

• Clinicians reduce waiting lists and appointments, freeing time for patients who need urgent care

• Healthcare providers see faster results and more efficient diagnostic pathways